Abstract Proteomics research has taken up an increasingly important role in life sciences over the past few years. Due to a strong push from publishers and funders alike, the community has also started to freely share its data in earnest, making use of public repositories such as the highly popular PRIDE database at EMBL-EBI. Reuse of these publicly available data has so far been confined to rather specific, targeted reanalyses, but this limited reuse is set to expand dramatically as repositories continue to grow exponentially. Examples of large-scale reuse are readily found in other omics disciplines, where more comprehensive public data have already accumulated over longer periods. Here, a typical example of integrative data reuse is provided by the construction of so-called expression atlases. We here therefore investigate the issues involved in using the human data currently stored in the PRIDE database to construct a robust, tissue-specific protein expression atlas from tandem-MS based label-free quantification.
Introduction
Mass spectrometry-based proteomics has become a key tool in life sciences during the past few years [1] . Building on the advent of novel instruments, powerful analytical methods, and improved algorithms, the throughput of the analyses has also increased dramatically, resulting in larger amounts of data collected per experiment. The increased use of proteomics as a key analytical technique and the larger amount of data acquired in each application have together led to an enormous growth in the production of proteomics data. Fortunately, these interesting data are increasingly captured by centralized, public repositories such as GPMDB [2] , PRIDE [3] , and PeptideAtlas [4] , especially since thresholds to submission have been lowered very effectively through the development of user-friendly submission and annotation software [5, 6] . This trend to collect, store, and disseminate all relevant data within a particular omics domain is nothing new. Indeed, structural data on proteins have been accumulating in the Protein Data Bank for decades [7] while the human genome project illustrated quite clearly the seedcrystal effect of disseminating large-scale omics data through centralized public repositories. The omics field that is perhaps closest to proteomics in concept is transcriptomics, and here too data collection efforts have already been firmly established [8, 9] . Because transcriptomics is quite comparable to proteomics, and because the former field is a few years ahead of the latter in terms of centralized data collection, there is the intriguing possibility to extrapolate the coming trends in the field of proteomics from what has transpired in transcriptomics. At this point in the development of proteomics, it is particularly interesting to look at potential use cases for the large amounts of publicly available data that are currently being amassed. While initial efforts at data reuse have so far focused on rather specific and largely technical endeavours (e.g. spectral library building [10] or fragmentation variability analysis [11, 12] ), some initial efforts at a meta-analysis across several experiments in the public domain to look at tissue-specific expression profiles have been undertaken as well [13, 14] . In transcriptomics on the other hand, data reuse has already taken a large stride forward, with comprehensive expression atlases built on integrated public data already available online [15, 16] . These atlases allow the user to compare expression profiles between tissues, or between healthy and disease states of the same tissue. Many other, typically highly focused gene expression atlases have also been built (e.g. [17] [18] [19] [20] ). For protein expression on the other hand, there are far fewer such resources currently available. Perhaps the most notable example is the Protein Atlas, based on highthroughput histological screening of tissue samples using antibody technology [21] . Interestingly, the usefulness of such an atlas as a platform for discovery-oriented in silico research has recently been shown by the detection of disease markers for particular types of cancer [22] . A very recent addition is MOPED [23] , a proteomics-based online database that currently relies primarily on select data sets processed through the in-house developed SPIRE processing pipeline [24] , although it is open to submissions that fulfil certain annotation requirements.
Yet in order to establish a proteomics expression atlas that is similar to the existing transcriptomics equivalents, it is important to build a system that reuses all the data deposited in public repositories, as these systems are likely to continue to capture the vast majority of publicly available proteomics data [25] . However, integrating such heterogeneous data presents a serious technical challenge. We here therefore describe an investigation into the issues involved in constructing a robust pipeline for collecting, analysing, and then combining public human proteomics data from the PRIDE repository into a data matrix that can form the basis of a human proteomics atlas.
Materials and methods
All data was obtained from the public PRIDE database. Peptides were remapped onto their tandem-MS spectra, and protein inference was performed locally. Figure 1 shows the overall data processing steps employed, for which the details are given in the sections below, and in the results section
Data collection
All data was obtained from the PRIDE database at EBI (http://www.ebi.ac.uk/pride), using the public PRIDE MySQL instance on 19 December 2011. Only public experiments derived from human samples were used, resulting in 3,340 experiments, and these were further filtered to include only those experiments that contained at least 500 identified spectra, yielding 1,416 experiments. For each experiment, we retrieved the actual tandem-MS spectra, the peptide identifications as reported by the original submitter, and the experiment annotation in terms of sample. An overview table containing PRIDE accession numbers, creation dates, public record dates, and total peptide counts is provided in Table S1 in the Electronic supplementary material (ESM).
Spectrum to peptide remapping
All reported peptides were re-matched against their tandem-MS spectra using a universal annotation pipeline with a built-in adaptive noise filter. Calculated precursor ion mass-over-charge ratios (m/z) were compared with the recorded m/z in the spectrum, and if a discrepancy was found, it was attempted to resolve it using a predefined list of commonly encountered modifications in combination with sequence features. The modifications considered were: oxidation of methionine, pyro-glutamate formation for amino-terminal glutamine and glutamate, acetylation of peptide amino termini and lysine, and carbamidomethylation of cysteine. The number of times these modifications were used to annotate peptides in PRIDE is given in Table 1 . If the discrepancy between sequence and spectrum could not be resolved, the identification and spectrum were omitted from further analysis. For all retained peptide-to-spectrum matches, an adaptive noise filter was first applied to the spectrum using a robust statistical approach to detect the core distribution of random noise in the spectrum. For this, we applied an iterative robust statistical analysis called Winsorization on the peak intensities of the spectrum. This approach calculates the median and the median absolute deviation (MAD) for the peak intensities in the spectrum, and then compresses any intensity outside the range defined by the maximal allowed extreme values of median±1.5 times the MAD into those extremes. The median and MAD are then recalculated, and the process is iteratively carried forward until a predefined level of convergence is found for the difference between the MADs calculated in two subsequent iterations. This convergence criterion was here set at 10
. Theoretical b and y ions, both singly as well as doubly charged, were then calculated for the reported peptide sequence, taking into account any annotated modifications. Only b and y ions were considered to ensure stringent matching, with as few as possible false positive ion assignments. These theoretical fragments were then matched against the tandem-MS spectrum using a tolerance window determined from the PRIDE annotated analyser used for MS/MS: 0.6 Da for ion traps, and 0.3 Da for time-of-flight (TOF) devices (including Q-TOF machines). If more than one peak is found in a tolerance window, the most intense peak in the window was chosen as the matching peak. The total number of peaks and total intensity of the spectrum, as well as the number of matched peaks and the matched intensity were calculated for each spectrum. All results were then deposited in a locally built relational database, for which the schema is given in Fig. 2 . This database was used throughout this study.
Protein inference
Peptides were matched to proteins using a custom Perl script, with the human complement of UniProtKB/SwissProt [26] release 2011_12 (December 2011) as protein database. Possible removal of initiator methionines was taken into account during the mapping. All possible protein matches were recorded in the databases, allowing peptides that were unique to a particular protein to be distinguished from degenerate peptides that matched multiple proteins. Of the 218,679 input peptides, 48,703 could not be matched to UniProtKB/Swiss-Prot proteins, most likely due to sequences that were originally obtained from other databases, for which no equivalent is currently present in UniProtKB/ Swiss-Prot [27] . The final tally of mapped peptides thus constitutes 169,976. Such a unified protein inference against a single version of a reliable sequence database has been shown to greatly improve the overlap at the protein level between many independent peptide identifications that were originally performed over a long stretch of time [27] .
Results

Identification quality filtering
While the data obtained from the PRIDE database is typically deposited there in support of a published paper, the presence of a certain amount of false positives in each Fig. 1 Overall workflow used in this study. I m matched MS2 ion intensity, I t total MS2 ion intensity, S r retained amount of spectra, S t total amount of spectra. See main text for details dataset is practically certain. Indeed, many datasets are reported with an explicit 1 % or even 5 % false discovery rate (FDR) [28] . The issue with combining data across so many distinct experiments, each containing a small FDR, is that it can lead to a much larger total FDR for the merged data set, as random erroneous matches tend to add up quickly [29] . We therefore here apply an additional, global filter to further reduce the data set by removing potentially suspect peptide identifications. Our quality filter is derived from the ratio between the matched intensity and the total intensity of the spectra. A histogram plot of these ratios indicates that there are two overlapping ratio distributions (Fig. 3a) . Using an expectation maximization mixture modelling approach (from the 'mixtools' R library [30] ), the overall ratio distribution was split into two contributing distributions (Fig. 3a) , where we take the red distribution to be primarily composed of erroneous peptide assignments, and the green distribution to be mostly made up of correct Fig. 2 Relational database schema of the database used to store the original and calculated data used for this study peptide assignments. Based on this plot, and the separation of the two distributions, we chose a matched intensity versus total intensity ratio of 0.15 as the minimal cut-off. An estimated FDR is then calculated by dividing the area under the red curve over the interval (0.15 and 1) by the sum of the areas under the red and green curves over that same interval. This yields an estimated false discovery rate of 7.7 %. Filtering by this threshold reduces the amount of spectra in the data set from 1,719,907 to 1,199,318, removing approximately 30 % of the spectra. We can further verify whether certain experiments are disproportionally affected by this cut-off, by plotting the distribution of the percentage of retained spectra per experiment after filtering (see Fig. 3b ). From the figure, it is clear that we here again have two partially overlapping distributions, one where the losses are large (typically over 50 % of spectra in these experiments are removed), and one where the majority of spectra is retained. By employing the same mixture modelling approach described above, we chose to exclude all data from experiments that retained less than 65 % of their spectra after filtering (the area under the red curve takes up 8.1 % of the total area under the red and green curves over the interval (0.65 and 1.0)). It is noteworthy that such simple yet universal metrics could potentially be used for largescale quality control of public data sets, in addition to existing measures discussed previously by Foster and colleagues [31] . At the end of this data culling exercise, we are left with 1,022,111 spectra, thus eliminating a little over 40 % of all downloaded spectra in order to retain only the highest quality identifications. The impact of these consecutive filters on peptide-to-spectrum matches, unique peptide sequences, and experiments are given in Table 2 .
Spectral intensity normalization across experiments
When comparing tandem-MS spectral intensities across a large number of heterogeneous experiments, it is important to ascertain a priori whether the data is in fact comparable.
To this end, we analysed the overall spectral intensity distributions per experiment. A representative sampling of spectral intensities from 20 experiments is shown as boxplots in Fig. 4a . As can be clearly seen in this plot, the intensities are not immediately comparable, showing a large amount of heterogeneity between experiments. We therefore used the quantile normalization function of the preprocessCore library in BioConductor [32] in R to normalize the intensity distributions. The resulting normalized intensities for the 20 experiments are shown in Fig. 4b , displaying a marked improvement in comparability of the intensities (B) The distribution and histogram (both in black) of the recovery ratio of spectra for each experiment after the application of the quality filter derived from (A). Based on this analysis, all experiments that retained less than 65 % of their spectra were omitted PSM peptide-to-spectrum, I m matched MS2 ion intensity, I t total MS2 ion intensity, S r retained amount of spectra, S t total amount of spectra across experiments. The effects of this normalization carry through quite distinctly to the level of peptides, and further on to proteins, although a slight increase in variability can be observed at these levels (see Fig. 1 in the ESM). Such normalization is thus important and useful for the aggregation and comparison of across-experiment intensity-based analyses. Indeed, a similar effect has already been demonstrated for various within-spectrum normalization methods with regards to the reproducibility of same-peptide fragmentation spectra [33] , and for the integration of precursor intensity-based quantification results from various algorithms [34] .
Ability of shared peptides to resolve protein inference
As an example of an in silico research approach that is readily supported by this type of data, we verified whether normalized matched spectral intensity could be used as a means to resolve the protein inference problem, as originally suggested by Nesvizhskii and Aebersold [35] . Since protein inference issues can become unresolvable very quickly [36] , we analysed only the simplest possible case. We retained only those proteins that had both unique matching peptides as well as degenerate peptides, but we imposed on the latter that they could not match more than two proteins. We thus selected for proteins that had unique peptides, allowing us to calculate an unambiguous baseline quantification for that protein, but that also shared one or more peptides with only one other protein per peptide, and this other protein also must have unique peptides assigned to it. We now stipulate that in order to be useful as tools in deciding protein inference, the shared peptides should deliver quantification results that could clearly indicate the presence of one protein, even if only that shared peptide was detected for that protein, along with a host of unique peptides for the other protein.
In our setup, we could calculate three distributions per protein-pair that was connected by at least one shared peptide: a mean and standard deviation m 1 and s 1 from the unique peptides for one protein in the pair, a mean and standard deviation m 2 and s 2 from the unique peptides for the other protein in the pair, and the combined mean m 3 and s 3 according to the following standard formulae:
Note that these calculates require that at least three unique peptides are found for each protein in the pair. This condition was therefore also imposed on our selected protein pairs. Ideally, a peptide shared between two proteins should yield a quantification value that is significantly different from the quantification results obtained for each protein in the pair using only their unique peptides, but this value should at the same time be contained in the distribution defined by the sum of averages of the quantification results for each individual protein. Indeed, the quantity of the shared peptides can be expected to be the sum of the quantity of the first protein and the quantity of the second protein. We therefore calculated three z-scores for each such shared peptide: (1) z 1 was calculated for the distribution formed by N( m 1 , s 1 ), (2) z 2 for N~(m 2 , s 2 ), and (3) z 3 for N~(m 3 , s 3 ). The generic formula for these z-scores is given below:
With I ps the normalized matched intensity of the shared peptide.
We found 961 such protein pairs where each protein had at least three unique peptides while also sharing at least one peptide per protein pair. We then calculated the three abovementioned z-scores for each spectrum of each shared peptide identification among these 961 pairs. With 2,813 shared peptides, represented by a total of 52,882 spectra, we could therefore calculate 52,822 z-score triplets. Interestingly, only 2,250 (4.3 %) had a z 1 and z 2 above 2, but a z 3 below 2. Note that a z-score higher than 1.96 indicates a significant difference from the corresponding mean at the 95 % confidence interval if a normal distribution is assumed. This indicates that the assumption does not hold that shared peptides yield a quantification that can be estimated by the sum of the average quantifications of each protein in the corresponding pair. Furthermore, there are 37,852 instances (72 %) where both z 1 and z 2 are below 2, indicating that it would not be easy to use their quantification to tell a shared peptide from the unique peptides for either protein in the pair. As a result, it seems to be exceedingly difficult to utilize the matched intensity from fragmentation spectra to distinguish between shared and unique peptides, let alone to use this information to resolve the protein inference problem. This situation may come about because of the relatively poor resolution of such label-free approaches [37, 38] , and may well yield better performance when higher-resolution label-based strategies are employed [39] .
Discussion
We have here analysed the hurdles encountered when attempting to integrate a posteriori extracted, tandem-MSbased quantitative data from the PRIDE public proteomics data repository to ultimately serve as the basis for a human proteomics atlas project. Because of the inherent heterogeneity of the data across so many independent experiments, each stage of the data collection and analysis must be accompanied by additional processing efforts in order to ensure the quality and comparability of the results. We therefore performed an independent matching between each reported peptide sequence and its identifying fragmentation spectrum, thus unifying the way in which noise peaks are filtered and fragment ions are identified in the spectra. It was also crucial to normalize spectral intensities per experiment to make them readily comparable across experiments, a process in which we could borrow successfully from efforts developed for the field of microarray analysis. Furthermore, the mapping of peptides to proteins had to be performed anew, using a single reference protein database. Here, a substantial amount of peptides is lost due to their absence from the sequence database, illustrating an important and as yet largely unmet role for proteomics data to serve in the annotation of sequence databases. Another major source of data loss occurs in the quality filtering steps, with over 40 % of spectra removed in this case. This large data loss may be caused by employing filters that err on the side of caution, thus removing too many correctly identified spectra. When building an expression atlas that could be useful to life sciences researchers outside the core field of proteomics however, such stringent filtering is probably justified since it ensures that reliability of the results. Other use cases for these data may utilize different filtering criteria, depending on the requirements at hand, as we showed previously [31] . As such, pre-filtering data deposited in repositories poses an important problem since any quality-based data reduction at the point of deposition will necessarily lead to irrevocable data loss from the point of view of low-quality tolerant use cases. As such, it seems to be best to create a two-layered repository, in which the submission layer consists of raw, deposited data, and the quality-controlled layer contains only those data that pass stringent quality filters. This type of system is in place in several well-known databases in some shape or form, including Ensembl (ab initio peptide sets versus validated peptide sets) and UniProtKB (the TrEMBL versus the Swiss-Prot complement). Yet, it is noteworthy that even despite these large overall losses during our stringent processing and interpretation of the data, more than one million high-quality quantifiable spectra remain for human samples alone. Since the PRIDE repository is still growing exponentially, this amount of available highquality data will only increase, permitting the creation of a comprehensive atlas in the foreseeable future. We therefore expect to see an increased interest in the downstream processing of a data matrix such as the one we were able to construct here by rematching, remapping, normalizing, and quality filtering the raw information obtained from the PRIDE data base. Indeed, although we here show that it is not trivial to attempt the construction of such an atlas, it is nevertheless feasible. Importantly, established efforts in other omics disciplines have illustrated that such work is highly rewarding, serving as a springboard for further in silico research that can yield both increased understanding of the technology, as well as insight into the underlying biology.
